Market Tracker

08/31 4:35am ET

Incyte Corp (NASDAQ:INCY)

119.93
Delayed Data
As of Aug 28
 +6.08 / +5.34%
Today’s Change
43.86
Today|||52-Week Range
121.70
+64.04%
Year-to-Date

Today’s Trading

Previous close113.85
Today’s open113.15
Day’s range112.13 - 120.00
Volume1,816,063
Average volume (3 months)1,106,381
Market cap$21.6B
Dividend yield--
Data as of 08/28/2015

Growth & Valuation

Earnings growth (last year)+48.21%
Earnings growth (this year)+31.22%
Earnings growth (next 5 years)+199.00%
Revenue growth (last year)+44.10%
P/E ratio1,555.5
Price/Sales24.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+2.29+1.75%
ZTSZoetis Inc-0.08-0.17%
MYLMylan NV-1.12-2.18%
ENDPEndo International P...-0.30-0.38%
Data as of 08/28/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$511.5M
Annual profit (last year)-$48.5M
Net profit margin-9.48%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts